SEBIO 2013 Board of Directors

Officers:
Chair: Becky Kaufman, King & Spalding LLP
Vice-Chair and Secretary: Sue Washer, AGTC
Treasurer: Mark Baxter, Ernst & Young
Ex Officio: Aaron Davidson, H.I.G. BioVentures

Executive Committee:
Brian Adams, Arbor Pharmaceuticals, Inc.
Mark Baxter, Ernst & Young
Kathy Carr, Tall Oaks Capital
Aaron Davidson, H.I.G. BioVentures
David Day, University of Florida, Office of Technology Licensing
Tim Gupton, Hughes Pittman & Gupton, LLP
Mike Gutch, MedImmune Ventures
Frank Hunt, PNP Therapeutics, Inc.
Becky Kaufman, King & Spalding LLP
Ed Mathers, NEA
Tina McKeon, Kilpatrick Townsend & Stockton, LLP
Doug Reed, Hatteras Venture Partners
Ken Tindall, North Carolina Biotechnology Center
Sue Washer, AGTC
Dave Winwood, UAB Research Foundation

Directors:
Russell Allen, Georgia Bio
Greg Anglum, Grant Thornton
Mark Augusti, Bioventus
William Brooke, Harbert Venture Partners
Gerry Brunk, Lumira Capital
Tom Callaway, Life Science Partner
Kathy Carr, Tall Oaks Capital
Susan Casey, Square 1 Bank
Mark Crowell, University of Virginia
Steve Hall, Lilly Ventures
Jeff Gallagher, Virginia Bio
Rick Kent, Intersouth Partners
Garheng Kong, Sofinnova Ventures
Dan Myers, Alimera Sciences, Inc.
Kathy Nugent, BioAlabama
Matt Rieke, Quaker Partners
Rose Ritts, Duke University, Office of Licensing & Ventures
Larry Robbins, Wyrick Robbins Yates & Ponton, LLP
Wayne Roper, SCBIO
Seth Rudnick, Canaan Partners
Jennifer Sherer, SEBIO
Todd Sherer, Emory University, Office of Technology Transfer
Susan Shows, Georgia Research Alliance
Philip Street, Paul Hastings, LLP
Samuel Taylor, NCBIO
Abby Trotter, Life Science Tennessee
Miriam Wilson, Council for Entrepreneurial Development (CED)
Bill Wofford, Hutchison Law Group
Ford Worthy, Pappas Ventures